Teva is voluntarily recalling a single lot of Anagrelide Capsules, USP 0.5mg, due to dissolution failure that was detected during a routine stability test. Teva is voluntarily recalling a single lot ...
Pharmaceutical labs face constant pressure to deliver precise, reproducible dissolution results while staying compliant with regulatory standards. ERWEKA’s Digital Dissolution Offline System ...
Dissolution and drug release tests are directly relevant to the safety and efficacy of many common pharmaceutical dosage forms. To achieve reliable and reproducible results, analysts must understand ...
Dissolution testing plays an important role throughout the life cycle of a pharmaceutical product, i.e., from evaluating how quickly a compound dissolves into solution in controlled conditions to ...
Teva Pharmaceuticals USA has initiated a voluntary nationwide recall of a single lot of Anagrelide Capsules, USP 0.5 mg (Lot number GD01090), to the consumer level in the United States. This voluntary ...
You need to enable JavaScript to run this app. You need to enable JavaScript to run this app. RAPS.org needs your explicit consent to store browser cookies. If you ...
Jubilant Cadista has issued a voluntary recall of one lot of birth control pills produced under contract by Cyndea Pharma in Spain because it failed dissolution tests. The recall covers blister packs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results